HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Chen Selected Research

4-Aminobutyrate Transaminase (4 Aminobutyrate Transaminase)

7/2021Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.
1/2021Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Chen Research Topics

Disease

7Neoplasms (Cancer)
03/2022 - 05/2009
4Glioma (Gliomas)
03/2022 - 05/2009
4Brain Neoplasms (Brain Tumor)
03/2012 - 04/2010
2Medulloblastoma
07/2021 - 01/2021
1Glioblastoma (Glioblastoma Multiforme)
03/2022
1Cardiotoxicity
12/2021
1Heart Failure
12/2021
1Supraventricular Tachycardia
12/2021
1Fever (Fevers)
12/2021
1COVID-19
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Sepsis (Septicemia)
09/2020
1Cataract (Cataracts)
07/2020
1Embolism (Embolus)
01/2020
1Stroke (Strokes)
01/2020
1Venous Thromboembolism
01/2020
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2019
1Blindness (Hysterical Blindness)
07/2018
1Nausea
12/2017
1Pain (Aches)
12/2017
1Melanoma (Melanoma, Malignant)
11/2016
1Keratoconjunctivitis Sicca
11/2015
1Glaucoma
07/2015
1Thrombocytopenia (Thrombopenia)
08/2011
1Urticaria (Hives)
08/2011
1Ovarian Neoplasms (Ovarian Cancer)
08/2011
1Neutropenia
08/2011
1Peritonitis
08/2011
1Corneal Diseases (Corneal Disease)
06/2010
1Autistic Disorder (Autism)
06/2007

Drug/Important Bio-Agent (IBA)

4Contrast MediaIBA
03/2012 - 04/2010
3Coomassie blueIBA
03/2012 - 05/2009
24-Aminobutyrate Transaminase (4 Aminobutyrate Transaminase)IBA
07/2021 - 01/2021
2Peptides (Polypeptides)IBA
03/2012 - 05/2009
2polyacrylamideIBA
03/2012 - 05/2009
1AcidsIBA
03/2022
1osimertinibIBA
12/2021
1trametinibIBA
12/2021
1dabrafenibIBA
12/2021
1alectinibIBA
12/2021
1ceritinibIBA
12/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021
1brigatinibIBA
12/2021
1Gefitinib (Iressa)FDA Link
12/2021
1AntipyreticsIBA
12/2021
1CrizotinibIBA
12/2021
1AfatinibIBA
12/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2021
1lorlatinibIBA
12/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2021
1Antihypertensive Agents (Antihypertensives)IBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2021
1Histones (Histone)IBA
01/2021
1Alkynes (Acetylenes)IBA
09/2020
1GlycosidesIBA
09/2020
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2020
1betrixabanIBA
01/2020
1RivaroxabanIBA
01/2020
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2019
1Caspofungin (Cancidas)FDA Link
01/2019
1Anti-Anxiety Agents (Anxiolytics)IBA
12/2017
1SCH772984IBA
11/2016
1Naltrexone (ReVia)FDA LinkGeneric
11/2015
1Glutamic Acid (Glutamate)FDA Link
07/2015
1Glutathione (Reduced Glutathione)IBA
07/2015
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
03/2012
1HydrogelsIBA
03/2012
1Fluorescent Dyes (Fluorescent Probes)IBA
11/2011
1CreatinineIBA
08/2011
1Cisplatin (Platino)FDA LinkGeneric
08/2011
1Topotecan (Hycamtin)FDA LinkGeneric
08/2011
1PlatinumIBA
08/2011
1CyanoacrylatesIBA
01/2011
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
05/2009
1Coloring Agents (Dyes)IBA
05/2009
1Cell Surface ReceptorsIBA
05/2009
1Methylene Blue (Methylthioninium Chloride)FDA Link
05/2009
1NucleolinIBA
05/2009
1Oxytocin (Pitocin)FDA LinkGeneric
06/2007

Therapy/Procedure

3Therapeutics
12/2021 - 11/2016
2Length of Stay
12/2021 - 01/2020
2Phacoemulsification
07/2020 - 07/2018
1Lenses
03/2022
1Endoscopes
03/2022
1Patient Readmission
01/2020
1Aftercare (After-Treatment)
12/2017
1Acupuncture Therapy
12/2017
1Craniotomy
01/2011
1Topical Administration
06/2010